Newsfeeds - Spark Newswire

2 minute read

Virpax Pharma Highlights Results From Preclinical Dose Range Finding Studies For Its Envelta

Today, 2:54 PM

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing non-addictive product candidates for pain management, as well as PTSD, CNS

VRPX

1 minute read

Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-In-Human Study Of Epoladerm For Chronic Pain Associated With Osteoarthritis Of The Knee

By Bill Haddad

Today, 2:54 PM

Altasciences is pleased to have been chosen by Virpax® Pharmaceuticals, Inc. ("Virpax") (NASDAQ:VRPX) to conduct a first-in-human study of Epoladerm™ (diclofenac epolamine) for chronic pain associated

VRPX

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 2:54 PM

During Friday's session, 445 companies made new 52-week lows.

AAOI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 2:54 PM

Gainers

ACRX

2 minute read

FDA
News

Virpax Pharmaceuticals Says Anticipates Commencing Initial Human Trial For Epoladerm In Q2 2022

By Benzinga Newsdesk

Today, 2:54 PM

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are

VRPX

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 2:54 PM

ARDX

1 minute read

Watching Datchat, Phunware, Paysafe, Virpax Pharma; Traders Circulate PennyStocks.com Article Mentioning Stocks

By Benzinga Newsdesk

Today, 2:54 PM

https://pennystocks.com/featured/2021/12/08/4-reddit-penny-stocks-to-buy-under-5-trump-stocks-jump/

DATS

1 minute read

Virpax Pharma Reports Results Of Toxicology, Pharmacokinetic Study For Epoladerm: Single-Dose Transdermal Delivery Was Well Tolerated In All Minipigs, No Treatment-Related Clinical Observations

By Benzinga Newsdesk

Today, 2:54 PM

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,

VRPX

1 minute read

Virpax Reports Signed Deal With Sinclair Research To Initiate Investigational New Drug-Enabling Studies For AnQlar

By Benzinga Newsdesk

Today, 2:54 PM

Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,

VRPX

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:54 PM

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.

ACH